COVID-19 Saliva Screening Test Potential Market

COVID-19 Saliva Screening Test Potential Market Size, Share, Growth Analysis, By Location(Travel Stations, Airports, Cruise, Ports), By Location(Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments), By Technology(Fluorescence-labeled antigen/antibodies testing, RT-PCR, CRISPR-Cas9), By Mode(Centralized Testing, Decentralized Testing), By Region(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35A2497 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

COVID-19 Saliva Screening Test Potential Market Insights

Market Overview:

The estimated market size for COVID-19 saliva screening tests in 2020 was USD 2955.9 billion, and from 2021 to 2023, it is anticipated to rise at a CAGR (compound annual growth rate) of 4.8%. These projections depict a potential market size for the COVID-19 saliva test for screening in the event that end-use locations have a population attendance of 60.0% (pre-COVID attendance rate) and a testing rate of 100.0% using the COVID-19 saliva screen test equipment. Due to its ease of use, patient friendliness, and speedier test-to-result turnaround, saliva-based screening for SARS_CoV-2 is growing in popularity.

COVID-19 Saliva Screening Test Potential Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for COVID-19 Saliva Screening Test Potential was estimated to be valued at US$ XX Mn in 2021.

The COVID-19 Saliva Screening Test Potential Market is estimated to grow at a CAGR of XX% by 2028.

The COVID-19 Saliva Screening Test Potential Market is segmented on the basis of Location, Location, Technology, Mode, Region.

Based on region, the COVID-19 Saliva Screening Test Potential Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the COVID-19 Saliva Screening Test Potential Market are , ARUP Laboratories, Vatic Health, MOgene, Psomagen Inc., DxTerity Diagnostics, Inc., Ambry Genetics, Fluidigm Corporation, Phosphorus Diagnostics LLC, Gravity Diagnostics, DNA Genotek, Inc., Quidel Corporation, Abbott, LumiraDX, FluroTech Ltd..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

COVID-19 Saliva Screening Test Potential Market

Report ID: UCMIG35A2497

$5,300
BUY NOW GET FREE SAMPLE